Marinus Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company dedicated to the development of ganaxolone, which offers a new mechanism of action, an extensive safety database, and convenient dosing to improve the lives of patients suffering from drug-resistant seizures and neuropsychiatric disorders.


Clinical Trials

Physicians and patients learn more about ganaxolone and Marinus Pharmaceuticals’ clinical trials here.

View Pipeline >

Follow Us on Twitter

Marinus Pharma's Twitter avatar
Marinus Pharma

Most new moms experience #babyblues. However, according to the @APA, 1 in 7 women suffer from #postpartumdepression… t.co/1pHtc5ygwh